Table 1 MCL patients’ characteristics and clinical-pathologic features for the whole cohort and different racial groups
From: Racial differences in mantle cell lymphoma in the United States
|  | Total (n = 2958) | Non-Hispanic white (n = 2620) | Hispanic white (n = 109) | Black (n = 121) | Asian/PI (n = 108) | P |
|---|---|---|---|---|---|---|
Gender | Â | Â | Â | Â | Â | 0.043 |
Male | 1989 (67.2) | 1775 (67.7) | 77 (70.6) | 68 (56.2) | 69 (63.9) | Â |
Female | 969 (32.8) | 845 (32.3) | 32 (29.4) | 53 (43.8) | 39 (36.1) | Â |
Marital Status | Â | Â | Â | Â | Â | <0.001 |
Single | 243 (8.7) | 195 (7.9) | 20 (20.8) | 21 (18.8) | 7 (6.8) | Â |
Married | 1905 (68.4) | 1721 (69.6) | 59 (61.5) | 48 (42.9) | 77 (74.8) | Â |
Separated/divorced/widowed | 636 (22.8) | 557 (22.5) | 17 (17.7) | 43 (38.4) | 19 (18.4) | Â |
Age at diagnosis | 67.8 ± 12.3 | 68.2 ± 12.1 | 64.3 ± 12.7 | 62.8 ± 13.7 | 67.0 ± 12.1 | <0.001 |
Stage | Â | Â | Â | Â | Â | 0.029 |
Stage I | 396 (14.1) | 338 (13.6) | 20 (20.2) | 18 (15.8) | 20 (18.7) | Â |
Stage II | 251 (8.9) | 219 (8.8) | 8 (8.1) | 9 (7.9) | 15 (14.0) | Â |
Stage III | 411 (14.7) | 357 (14.4) | 17 (17.2) | 26 (22.8) | 11 (10.3) | Â |
Stage IV | 1747 (62.3) | 1571 (63.2) | 54 (54.5) | 61 (53.5) | 61 (57.0) | Â |
B symptoms | Â | Â | Â | Â | Â | 0.108 |
No | 1070 (36.2) | 949 (36.2) | 47 (43.1) | 36 (29.8) | 38 (35.2) | Â |
Yes | 596 (20.1) | 513 (19.6) | 23 (21.1) | 35 (28.9) | 25 (23.1) | Â |
Unknown | 1292 (43.7) | 1158 (44.2) | 39 (35.8) | 50 (41.3) | 45 (41.7) | Â |
Extranodal involvement | Â | Â | Â | Â | Â | <0.001 |
No | 2478 (83.8) | 2206 (84.2) | 93 (85.3) | 106 (87.6) | 73 (67.6) | Â |
Yes | 480 (16.2) | 414 (15.8) | 16 (14.7) | 15 (12.4) | 35 (32.4) | Â |
Survival time (month) (Median ± SD) | 46.0 ± 1.8 | 46.0 ± 1.9 | 57.0 ± 13.5 | 39.0 ± 7.9 | 46.0 ± 6.8 | 0.735 |